Sopharma AD-Sofia 3JR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €2.44
- Day Range
- €2.59–2.59
- 52-Week Range
- €1.50–2.80
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 538.41M
- Market Cap
- €1.39B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 18.30
- Price/Sales
- 1.07
- Dividend Yield (Trailing)
- 2.01%
- Dividend Yield (Forward)
- 4.02%
- Dividend Payment Schedule
- Aug
- Total Yield
- 2.01%
Company Profile
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 6,049
- Website
- https://www.sopharmagroup.com
Valuation
|
Metric
|
3JR
|
|---|---|
Price/Earnings (Normalized) | 18.30 |
Price/Book Value | 2.83 |
Price/Sales | 1.07 |
Price/Cash Flow | 25.63 |
Price/Earnings
3JR
Financial Strength
|
Metric
|
3JR
|
|---|---|
Quick Ratio | 0.70 |
Current Ratio | 1.43 |
Interest Coverage | 9.21 |
Quick Ratio
3JR
Profitability
|
Metric
|
3JR
|
|---|---|
Return on Assets (Normalized) | 7.57% |
Return on Equity (Normalized) | 16.01% |
Return on Invested Capital (Normalized) | 10.60% |
Return on Assets
3JR
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|b@>v#! | LOCK|tzk%> | $116B | |||
| Cencora Inc
COR
| LOCK|Yrb!$Y< | LOCK|XS%W% | $65B | |||
| Cardinal Health Inc
CAH
| LOCK|H>!JHX | LOCK|P@f> | $59B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|gR%< | $23B | |||
| Henry Schein Inc
HSIC
| LOCK|m#x>gKr | LOCK|K!JxK | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|MwM | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|qS | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|&T | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|v<K!g | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|b^ | $4B |
United States